Status:
UNKNOWN
An Assessment of the Occurrence of Hormone Deficiency in Patients With Empty Sella
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Empty Sella
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this prospective study is to analyse the hormonal components in the blood of patients that were diagnosed with empty sella. Hereby we only take the hormones into consideration that are pro...
Eligibility Criteria
Inclusion
- Patients that were diagnosed with an (partial) empty sella detected by MRI or CT of the brain have been included in this study. Whenever the MRI or CT scan was performed more than two years ago, a new MRI scan was required.
Exclusion
- Children (patients less than 18 years) and patients with earlier diagnosed carcinomas of the brain as well as patients with secondary empty sella (antecedents of radiation, pharmacological treatment of pituitary adenomas, traumatic head injury and surgery of the pituitary gland as well as the central nervous system) were not included.
Key Trial Info
Start Date :
October 14 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04700020
Start Date
October 14 2019
End Date
May 1 2021
Last Update
January 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitair Ziekenhuis Brussel
Brussels, Jette, Belgium, 1090